Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Altria Group’s second quarter and first half 2026 results illustrate steady execution across its core tobacco and nicotine product segments amid a challenging consumer and macroeconomic environment.</li><li>The company’s strategy focuses on balancing growth in its smoke-free portfolio, particularly nicotine pouches, while maintaining strength in its traditional tobacco products and returning significant value to shareholders.</li><li>In the nicotine pouch category, Altria’s Helix subsidiary expanded the on!</li></ul>

Altria Group’s second quarter and first half 2026 results illustrate steady execution across its core tobacco and nicotine product segments amid a challenging consumer and macroeconomic environment.The company’s strategy focuses on balancing growth in its smoke-free portfolio, particularly nicotine pouches, while maintaining strength in its traditional tobacco products and returning significant value to shareholders.In the nicotine pouch category, Altria’s Helix subsidiary expanded the on!

Altria Group’s 120,000-Store Nicotine Push — Can on! PLUS Become Its Next Growth Engine?

Independent in-depth research from Finimize, Finimize

Finimize Research

Independent in-depth research from Finimize

Finimize

Finimize is the #1 information platform for modern investors. We empower people to become smarter investors with bitesize insights from world-class analysts. 1 million+ strong community, 250 partners.

Thematic (Sector/Industry)

<ul>
<li>The US economy’s resilience hasn’t come from the many – it’s come from the top 10% as the “wealth effect” from rising asset prices has boosted spending.</li>
<li>But it works in reverse too.  Since the richest make up nearly half of America’s consumer spending, that could lead to a serious economic fallout.</li>
<li>It’s worth considering protecting your portfolio. I’ve pulled together one list of companies that should do well and another that could suffer from the change in climate.</li>
</ul>


The US economy’s resilience hasn’t come from the many – it’s come from the top 10% as the “wealth effect” from rising asset prices has boosted spending.
But it works in reverse too.  Since the richest make up nearly half of America’s consumer spending, that could lead to a serious economic fallout.
It’s worth considering protecting your portfolio. I’ve pulled together one list of companies that should do well and another that could suffer from the change in climate.


A Defensive Portfolio Prepared For The Wealth Effect’s Reversal

<ul><li>Altria Group delivered a stronger first quarter than initially implied by its full-year phasing expectations, supported by resilient smokeable products profitability, favorable net pricing, moderated cigarette volume pressure and continued shareholder returns.</li><li>Adjusted diluted EPS increased 7.3%, while the smokeable products segment generated 6.3% adjusted operating companies income growth and expanded adjusted margins to 65.1%.</li><li>Management attributed the better start mainly to reduced cross-category movement from cigarettes into illicit flavored disposable e-vapor products, which helped domestic cigarette volume declines moderate.</li></ul>

Altria Group delivered a stronger first quarter than initially implied by its full-year phasing expectations, supported by resilient smokeable products profitability, favorable net pricing, moderated cigarette volume pressure and continued shareholder returns.Adjusted diluted EPS increased 7.3%, while the smokeable products segment generated 6.3% adjusted operating companies income growth and expanded adjusted margins to 65.1%.Management attributed the better start mainly to reduced cross-category movement from cigarettes into illicit flavored disposable e-vapor products, which helped domestic cigarette volume declines moderate.

Altria Group: The Illicit E-Vapor Headwind Is The Structural Pressure The Volume Trends Mask!

<ul><li>Altria Group, a leading tobacco company, reported its 2025 fourth-quarter and full-year earnings, revealing a mix of strategic advancements and challenges.</li><li>The company achieved a 4.4% increase in adjusted diluted earnings per share over the year and returned $8 billion to shareholders through dividends and share repurchases.</li><li>A significant positive aspect of Altria's performance in 2025 was its progress in developing a smoke-free product portfolio.</li></ul>

Altria Group, a leading tobacco company, reported its 2025 fourth-quarter and full-year earnings, revealing a mix of strategic advancements and challenges.The company achieved a 4.4% increase in adjusted diluted earnings per share over the year and returned $8 billion to shareholders through dividends and share repurchases.A significant positive aspect of Altria's performance in 2025 was its progress in developing a smoke-free product portfolio.

Altria Group Inc.: Inside Altria’s Nicotine Pouch Push—What’s Driving the Surge in on! PLUS?

<ul><li>Altria Group's recent earnings call highlighted several elements of its business strategy and financial performance, presenting both positive and negative aspects that investors may consider.</li><li>Altria reported strong financial outcomes for the third quarter and the first nine months of the year, with adjusted diluted earnings per share (EPS) increasing by 3.6% in the third quarter and 5.9% for the first nine months of the year.</li><li>However, the company faces challenges such as declining cigarette volumes and intensified competition in the nicotine pouch market.</li></ul>

Altria Group's recent earnings call highlighted several elements of its business strategy and financial performance, presenting both positive and negative aspects that investors may consider.Altria reported strong financial outcomes for the third quarter and the first nine months of the year, with adjusted diluted earnings per share (EPS) increasing by 3.6% in the third quarter and 5.9% for the first nine months of the year.However, the company faces challenges such as declining cigarette volumes and intensified competition in the nicotine pouch market.

Altria Group’s Bold New on! PLUS Launch Could Redefine the Future of Nicotine Innovation; But Is It Enough To Warrant A 'Buy' Rating?

United States

Altria Group, Inc. is a holding company.  The Company, through subsidiaries, manufactures and sells cigarettes and other tobacco products, including cigars and pipe tobacco.  Altria holds an interest in a brewery company.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Altria Group (MO US)

Altria Group’s 120,000-Store Nicotine Push — Can on! PLUS Become Its Next Growth Engine?

Altria Group’s second quarter and first half 2026 results illustrate steady execution across its core tobacco and nicotine product segments amid a...

Baptista Research

A Defensive Portfolio Prepared For The Wealth Effect’s Reversal

The top 10% account for around 50% of consumer spending in the US. This insight looks at the sectors and companies that could win and lose from the...

Finimize Research

Altria Group: The Illicit E-Vapor Headwind Is The Structural Pressure The Volume Trends Mask!

Altria Group delivered a stronger first quarter than initially implied by its full-year phasing expectations, supported by resilient smokeable...

Baptista Research

Altria Group Inc.: Inside Altria’s Nicotine Pouch Push—What’s Driving the Surge in on! PLUS?

Altria Group, a leading tobacco company, reported its 2025 fourth-quarter and full-year earnings, revealing a mix of strategic advancements and...

Baptista Research

Altria Group’s Bold New on! PLUS Launch Could Redefine the Future of Nicotine Innovation; But Is It Enough To Warrant A 'Buy' Rating?

Altria Group's recent earnings call highlighted several elements of its business strategy and financial performance, presenting both positive and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)